Search For "antibody"
Monoclonal antibodies prevent severe disease and deaths in high-risk patie
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], November 3 (ANI): Monoclonal Antibody therapy has been proven to be effective in reducing disease severity and chances of death in high-risk individuals infected with the Delta variant of COVID-19 by 100 per cent, as per a study by AIG Hospitals.
Read More
Scientists identify new antibody for COVID-19, variants
Updated : 4 years, 4 months ago IST
Washington [US], November 2 (ANI): Research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-1
Read More
Researchers identify unique genetic variants to overcome cancer treatment
Updated : 4 years, 4 months ago IST
Washington [US], October 27 (ANI): University of California, Los Angeles researchers add monoclonal antibody to target oropharyngeal cancer in HPV-positive patients with KRAS gene variant.
Read More
One in every two families paid over Rs 750 for COVID antibody test in Indi
Updated : 4 years, 6 months ago IST
New Delhi [India], September 3 (ANI): One in every two families paid over Rs 750 for the COVID antibody test in India, said a survey.
Read More
Study shows downside of not receiving second shot of COVID-19 vaccine
Updated : 4 years, 6 months ago IST
Washington [US], August 31 (ANI): A new study has shown that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 per cent in adults with prior cases of COVID-19. The study also tested how well current vaccines resist emerging variants.
Read More
Antibody protects against broad range of COVID-19 virus variants, study fi
Updated : 4 years, 6 months ago IST
Washington [US], August 21 (ANI): The virus that causes COVID-19 today is not the same as the one that made people fall sick way back in December 2019. Many of the variants circulating now are partially resistant to some of the antibody-based therapeutics that were developed based on the ori
Read More
Blood clots in people with severe COVID-19 may be related to abnormal anti
Updated : 4 years, 7 months ago IST
London [UK], July 28 (ANI): Inflammation and blood clotting seen in very severe cases of Covid-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs.
Read More
Larger population surveys required for deeper understanding of COVID-19, i
Updated : 4 years, 7 months ago IST
New Delhi [India], July 24 (ANI): After the release of the fourth round of the National Sero Survey results, health experts believe that larger population surveys are required for a deeper understanding of COVID-19 and its antibody response.
Read More
COVID-19 antibodies persist at least nine months after infection: Study
Updated : 4 years, 7 months ago IST
London [UK], July 20 (ANI): A new study led by researchers at Imperial College London and University of Padua shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Read More
Preliminary experiment of cocktail of two antibody drugs successful: BMC
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): The Brihanmumbai Municipal Corporation (BMC) on Monday informed that preliminary experiment of a cocktail of two antibody drugs -- Casirvimab and Imdevimab - has been successful.
Read More
Apart from Delta, Delta Plus too should be treated as variant of concern:
Updated : 4 years, 8 months ago IST
New Delhi [India], June 26 (ANI): Although there is no data as of now which shows that the Delta Plus variant of COVID-19 is spreading faster than Delta but the former should also be treated as a "variant of concern", said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Co
Read More
Delta Plus may not be important for transmissibility but perhaps crucial f
Updated : 4 years, 8 months ago IST
New Delhi [India], June 25 (ANI): Delta Plus or AY.1 will always remain a variant of concern (VoC) as it is mutated from the Delta variant (B.1.617.2), which is also a VoC, informed the Institute of Genomics and Integrative Biology (IGIB) on Friday.
Read More